Document is current
Any future updates will be listed below
-
Authors
Wiggins, Rebecca
Baisley, Kathy J.
Indangasi, Jackton
Changalucha, John
Ashwin, Helen
Brown, Najmeeyah
Whitworth, Hilary S.
Joakim, David
Mayaud, Philippe
Hashim, Ramadhan
Maxwell, Caroline
Mutani, Paul
Kamala, Beatrice
Lowe, Brett
Pinto, Ligia
Kemp, Troy
deSanjosé, Silvia
Kapiga, Saidi
Hayes, Richard J.
Watson-Jones, Deborah
Lacey, Charles J.
-
Funding
Funding for this research was provided by:
UK Dept for International Development/Medical Research Council/Wellcome Trust Joint Global Health Trials Scheme (MR/N006135/1)
UK Dept for International Development/Medical Research Council/Wellcome Trust Joint Global Health Trials Scheme (MR/N006135/1)
Bill and Melinda Gates Foundation (OPP1167526)
Bill and Melinda Gates Foundation (OPP1167526)
- License Information
-
More Information
Article History
Received: 16 June 2025
Accepted: 6 November 2025
First Online: 28 November 2025
Competing interests
: DW-J reports a grant from GSK Biologicals in 2007 for a previous study on safety and immunogenicity of Cervarix in Tanzania unrelated to this submitted work. Charles Lacey received HPV-16 and 18-L1 virus-like particles for the memory B-cell analysis of the DoRIS peripheral blood mononuclear cells (GSK grant HPV-095). All other authors declare no competing interests.
